Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

Financial Post

Image Credit: Financial Post

Please find more details at Financial Post

Summary

CRL Cites Deficiencies at Third-Party Manufacturing Facility No Efficacy or Clinical Safety Deficiencies Identified SEATTLE and VANCOUVER, British Columbia, June 22, 2026 (GLOBE NEWSWIRE) Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV),

Source: Financial Post

Read More

(0)

Exclusive AI-Powered News Insights (For Members only)

Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!